37043557|t|A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy.
37043557|a|Tauopathies are neurodegenerative diseases that are characterized by accumulation of hyperphosphorylated tau protein, higher-order aggregates, and tau filaments. Protein phosphatase 2A (PP2A) is a major tau dephosphorylating phosphatase, and a decrease in its activity has been demonstrated in tauopathies, including Alzheimer's disease. Prolyl oligopeptidase is a serine protease that is associated with neurodegeneration, and its inhibition normalizes PP2A activity without toxicity under pathological conditions. Here, we assessed whether prolyl oligopeptidase inhibition could protect against tau-mediated toxicity in cellular models in vitro and in the PS19 transgenic mouse model of tauopathy carrying the human tau-P301S mutation. We show that inhibition of prolyl oligopeptidase with the inhibitor KYP-2047 reduced tau aggregation in tau-transfected HEK-293 cells and N2A cells as well as in human iPSC-derived neurons carrying either the P301L or tau-A152T mutation. Treatment with KYP-2047 resulted in increased PP2A activity and activation of autophagic flux in HEK-293 cells and N2A cells and in patient-derived iNeurons, as indicated by changes in autophagosome and autophagy receptor markers; this contributed to clearance of insoluble tau. Furthermore, treatment of PS19 transgenic mice for 1 month with KYP-2047 reduced tau burden in the brain and cerebrospinal fluid and slowed cognitive decline according to several behavioral tests. In addition, a reduction in an oxidative stress marker was seen in mouse brains after KYP-2047 treatment. This study suggests that inhibition of prolyl oligopeptidase could help to ameliorate tau-dependent neurodegeneration.
37043557	2	23	prolyl oligopeptidase	Gene	19072
37043557	42	45	tau	Gene	4137
37043557	82	86	mice	Species	10090
37043557	92	101	tauopathy	Disease	MESH:D024801
37043557	103	114	Tauopathies	Disease	MESH:D024801
37043557	119	145	neurodegenerative diseases	Disease	MESH:D019636
37043557	208	211	tau	Gene	4137
37043557	250	253	tau	Gene	4137
37043557	289	293	PP2A	Gene	19052
37043557	306	309	tau	Gene	4137
37043557	397	408	tauopathies	Disease	MESH:D024801
37043557	420	439	Alzheimer's disease	Disease	MESH:D000544
37043557	441	462	Prolyl oligopeptidase	Gene	19072
37043557	508	525	neurodegeneration	Disease	MESH:D019636
37043557	557	561	PP2A	Gene	19052
37043557	579	587	toxicity	Disease	MESH:D064420
37043557	645	666	prolyl oligopeptidase	Gene	5550
37043557	700	703	tau	Gene	4137
37043557	713	721	toxicity	Disease	MESH:D064420
37043557	777	782	mouse	Species	10090
37043557	792	801	tauopathy	Disease	MESH:D024801
37043557	815	820	human	Species	9606
37043557	821	824	tau	Gene	4137
37043557	825	830	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
37043557	868	889	prolyl oligopeptidase	Gene	5550
37043557	909	917	KYP-2047	Chemical	MESH:C551540
37043557	926	929	tau	Gene	4137
37043557	945	948	tau	Gene	4137
37043557	961	968	HEK-293	CellLine	CVCL:0045
37043557	979	982	N2A	CellLine	CVCL:0470
37043557	1003	1008	human	Species	9606
37043557	1050	1055	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:2;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
37043557	1059	1062	tau	Gene	4137
37043557	1063	1068	A152T	ProteinMutation	tmVar:p|SUB|A|152|T;HGVS:p.A152T;VariantGroup:1;CorrespondingGene:4137;RS#:143624519;CorrespondingSpecies:9606;CA#:8617962
37043557	1094	1102	KYP-2047	Chemical	MESH:C551540
37043557	1125	1129	PP2A	Gene	5524
37043557	1176	1183	HEK-293	CellLine	CVCL:0045
37043557	1194	1197	N2A	CellLine	CVCL:0470
37043557	1211	1218	patient	Species	9606
37043557	1353	1356	tau	Gene	4137
37043557	1400	1404	mice	Species	10090
37043557	1422	1430	KYP-2047	Chemical	MESH:C551540
37043557	1439	1442	tau	Gene	4137
37043557	1498	1515	cognitive decline	Disease	MESH:D003072
37043557	1622	1627	mouse	Species	10090
37043557	1641	1649	KYP-2047	Chemical	MESH:C551540
37043557	1700	1721	prolyl oligopeptidase	Gene	5550
37043557	1747	1750	tau	Gene	4137
37043557	1761	1778	neurodegeneration	Disease	MESH:D019636
37043557	Negative_Correlation	MESH:C551540	RS#:143624519;HGVS:p.A152T;CorrespondingGene:4137
37043557	Association	MESH:D064420	4137
37043557	Negative_Correlation	MESH:D000544	19052
37043557	Negative_Correlation	MESH:C551540	RS#:63751273;HGVS:p.P301L;CorrespondingGene:4137
37043557	Positive_Correlation	MESH:D024801	RS#:63751438;HGVS:p.P301S;CorrespondingGene:4137
37043557	Association	MESH:D019636	4137
37043557	Association	19052	4137
37043557	Positive_Correlation	MESH:C551540	5524
37043557	Negative_Correlation	MESH:C551540	5550
37043557	Negative_Correlation	MESH:D024801	19052
37043557	Association	MESH:D019636	5550
37043557	Association	MESH:D024801	4137
37043557	Negative_Correlation	MESH:C551540	MESH:D003072
37043557	Association	19052	19072
37043557	Association	MESH:D019636	19072
37043557	Association	4137	5550
37043557	Negative_Correlation	MESH:C551540	4137

